Rapid Neutralizing Antibody Testing

 

Immune Monitoring for COVID-19
 

• Is there evidence of prior exposure to the SARS-CoV-2 virus, and
   

• ​Is there evidence that a robust immune response developed from infection or vaccination?

​Research is underway on the feasibility of a rapid test for the detection of COVID-neutralizing antibodies against Omicron and to determine if there was prior exposure to COVID-19. 

The rapid neutralizing antibody test is performed outside of a laboratory setting with results in 10-15 minutes.

 

 

  

Click on the video below to see how we will be implementing technology for a point-of- care rapid test.